[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100483033":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":31,"centralContacts":32,"locations":39,"responsibleParty":187,"collaborators":189,"id":212,"slug":213,"hasResults":214,"nctId":215,"briefTitle":216,"officialTitle":217,"acronym":218,"eligibilityCriteria":219,"healthyVolunteers":214,"sex":220,"minAge":221,"maxAge":31,"enrollmentInfo":222,"targetDuration":31,"studyType":225,"phases":226,"briefSummary":228,"conditions":229,"keywords":231,"overallStatus":42,"whyStopped":31,"lastUpdateSubmitDate":237,"lastUpdatePostDateStruct":238,"startDateStruct":241,"completionDateStruct":243,"leadSponsor":245,"locationsCount":246},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"semaglutide","ACTIVE_COMPARATOR","semaglutide SC once weekly, up titration over 2 month period to 1mg\u002Fweek (0.25mg once weekly, after 4 weeks 0.5mg once weekly and after 8 weeks the maintenance dose of 1mg once weekly), treatment duration of max. 3 years",[13],"Drug: Semaglutide Pen Injector",{"label":15,"type":16,"description":17,"interventionNames":18},"placebo","PLACEBO_COMPARATOR","placebo SC once weekly, the same dose-escalation regimen, using matching injections, treatment duration of max. 3 years",[19],"Drug: Semaglutide placebo",[21,28],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Semaglutide Pen Injector","maintenance dose of 1mg SC once weekly",[9],[27],"Ozempic",{"type":22,"name":29,"description":24,"armGroupLabels":30,"otherNames":31},"Semaglutide placebo",[15],null,[33],{"name":34,"role":35,"phone":36,"phoneExt":37,"email":38},"Katrien Benhalima, MD PhD","CONTACT","16340614","32","katrien.benhalima@uzleuven.be",[40,55,66,74,87,98,106,119,130,141,152,163,174],{"facility":41,"status":42,"city":43,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"AZORG","RECRUITING","Aalst","Belgium","BE",{"type":47,"coordinates":48},"Point",[49,50],4.0355,50.93604,{"lat":50,"lon":49},[53],{"name":54,"role":35,"phone":31,"phoneExt":31,"email":31},"Katrien Wierckx",{"facility":56,"status":42,"city":57,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"UZA","Antwerp",{"type":47,"coordinates":59},[60,61],4.40026,51.22047,{"lat":61,"lon":60},[64],{"name":65,"role":35,"phone":31,"phoneExt":31,"email":31},"Niels Bochanen",{"facility":67,"status":42,"city":57,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"ZAS",{"type":47,"coordinates":69},[60,61],{"lat":61,"lon":60},[72],{"name":73,"role":35,"phone":31,"phoneExt":31,"email":31},"Ann Verhaegen",{"facility":75,"status":42,"city":76,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":77,"geoPoint":81,"contacts":82},"AZ St Jan Brugge","Bruges",{"type":47,"coordinates":78},[79,80],3.22424,51.20892,{"lat":80,"lon":79},[83],{"name":84,"role":35,"phone":85,"phoneExt":31,"email":86},"Sara Vandewalle, MD","003250 45 23 3","SARA.VANDEWALLE@azsintjan.be",{"facility":88,"status":42,"city":89,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":90,"geoPoint":94,"contacts":95},"Erasme","Brussels",{"type":47,"coordinates":91},[92,93],4.34878,50.85045,{"lat":93,"lon":92},[96],{"name":97,"role":35,"phone":31,"phoneExt":31,"email":31},"Maria Lytrivi",{"facility":99,"status":42,"city":89,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":100,"geoPoint":102,"contacts":103},"UZ Brussel",{"type":47,"coordinates":101},[92,93],{"lat":93,"lon":92},[104],{"name":105,"role":35,"phone":31,"phoneExt":31,"email":31},"Nancy Van Wilder",{"facility":107,"status":42,"city":108,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":109,"geoPoint":113,"contacts":114},"Jan Yperman","Ieper",{"type":47,"coordinates":110},[111,112],2.88569,50.85114,{"lat":112,"lon":111},[115],{"name":116,"role":35,"phone":117,"phoneExt":31,"email":118},"An Nollet, MD","003257 35 72 70","an.nollet@yperman.net",{"facility":120,"status":42,"city":121,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"AZ Groeninge Kortrijk","Kortrijk",{"type":47,"coordinates":123},[124,125],3.26487,50.82803,{"lat":125,"lon":124},[128],{"name":129,"role":35,"phone":31,"phoneExt":31,"email":31},"Gertjan Vereecke",{"facility":131,"status":42,"city":132,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":133,"geoPoint":137,"contacts":138},"UZ Leuven","Leuven",{"type":47,"coordinates":134},[135,136],4.70093,50.87959,{"lat":136,"lon":135},[139],{"name":140,"role":35,"phone":31,"phoneExt":31,"email":31},"Katrien Benhalima",{"facility":142,"status":42,"city":143,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":144,"geoPoint":148,"contacts":149},"CHU de Liège","Liège",{"type":47,"coordinates":145},[146,147],5.56749,50.63373,{"lat":147,"lon":146},[150],{"name":151,"role":35,"phone":31,"phoneExt":31,"email":31},"JC Philips",{"facility":153,"status":42,"city":154,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":155,"geoPoint":159,"contacts":160},"Centre Hospitalier Mouscron","Mouscron",{"type":47,"coordinates":156},[157,158],3.20639,50.74497,{"lat":158,"lon":157},[161],{"name":162,"role":35,"phone":31,"phoneExt":31,"email":31},"Philippe Oriot",{"facility":164,"status":42,"city":165,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":166,"geoPoint":170,"contacts":171},"Vitaz","Sint-Niklaas",{"type":47,"coordinates":167},[168,169],4.1437,51.16509,{"lat":169,"lon":168},[172],{"name":173,"role":35,"phone":31,"phoneExt":31,"email":31},"Peter Coremans",{"facility":175,"status":42,"city":176,"state":31,"zip":31,"country":44,"countryCode":45,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"AZ Turnhout","Turnhout",{"type":47,"coordinates":178},[179,180],4.94471,51.32254,{"lat":180,"lon":179},[183],{"name":184,"role":35,"phone":185,"phoneExt":31,"email":186},"Joke Cuypers, MD","003214 44 44 32","joke.cuypers@azturnhout.be",{"type":188,"investigatorFullName":31,"investigatorTitle":31,"investigatorAffiliation":31,"oldNameTitle":31,"oldOrganization":31},"SPONSOR",[190,192,194,196,197,199,201,203,205,206,208,210],{"name":191,"class":6},"University Hospital, Antwerp",{"name":193,"class":6},"Universitair Ziekenhuis Brussel",{"name":195,"class":6},"General Hospital Groeninge",{"name":164,"class":6},{"name":198,"class":6},"Centre Hospitalier Universitaire de Liege",{"name":200,"class":6},"Erasme University Hospital",{"name":153,"class":202},"UNKNOWN",{"name":204,"class":6},"Jan Yperman Ziekenhuis",{"name":175,"class":6},{"name":207,"class":6},"AZ Sint-Lucas Brugge",{"name":209,"class":6},"Ziekenhuis aan de Stroom",{"name":211,"class":6},"Onze Lieve Vrouw Hospital","100483033","phase-3-semaglutide-for-the-treatment-of-glucose-intolerance-in-women-with-prior-gestational-diabetes-100483033",false,"NCT05569772","Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes","Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes: a Double Blind RCT","SERENA","Inclusion Criteria:\n\n1. Voluntary written informed consent of the participant has been obtained prior to any screening procedures\n2. Women aged ≥18 years\n3. Use of highly effective methods of birth control\n4. History of GDM diagnosed according to the 2013 WHO criteria (at 24-32 weeks gestation or \\\u003C24 weeks for early GDM)\n5. Diagnosis of prediabetes between 6 weeks and 12 months postpartum according to ADA criteria (FPG 5.6-6.9 mmol\u002FL, 2-hour OGTT glucose 7.8-11.0 mmol\u002FL and\u002For HbA1c 39-46 mmol\u002Fmol \\[5.7-6.4%\\])\n\nExclusion Criteria:\n\n1. Presence of autoantibodies suggestive of type 1 diabetes, normal glucose tolerance, history of pancreatitis, previous bariatric surgery or planned surgery within two years\n2. Unable to understand and speak Dutch, French or English\n3. Female who is pregnant or intends to become pregnant within the next year\n4. Female who wants to give breastfeeding \\>22 months\n5. Use of medication with significant impact on glycaemia (such as high dose glucocorticoids or metformin)","FEMALE","18 Years",{"count":223,"type":224},252,"ESTIMATED","INTERVENTIONAL",[227],"PHASE3","Gestational diabetes (GDM) is an important contributor to the increasing prevalence of type 2 diabetes (T2DM). Women with glucose intolerance in early postpartum are a particularly high-risk group with about 50% who will develop T2DM within 5 years after the delivery. Moreover, women with a history of GDM progress more rapidly to T2DM compared to women with similarly elevated glucose levels. Early intervention after the index pregnancy is therefore crucial to prevent T2DM. With the SERENA project, the investigators aim to reduce the risk to develop T2DM with the long-acting GLP-1 agonist semaglutide in women with a recent history of GDM and glucose intolerance in early postpartum.",[230],"Glucose Intolerance After a Recent History of Gestational Diabetes",[232,233,234,235,236,9],"gestational diabetes","glucose intolerance postpartum","prevention","type 2 diabetes","GLP-1 agonist","2026-05-28",{"date":239,"type":240},"2026-06-02","ACTUAL",{"date":242,"type":240},"2023-09-14",{"date":244,"type":224},"2029-12",{"name":5,"class":6},13]